OSTERI 750MCG INJECTION

Osteri  750mcg injection contains the active component known as Teriparatide. Osteri 750mcg injection, an artificial version of the Parathyroid Hormone (PTH) created by parathyroid glands, is utilized to treat osteoporosis. Osteoporosis is a disease characterized by weakened bones and an increased risk of breaking. Osteoporosis-related fractures can seriously affect a person’s health, which can cause pain and hinder mobility. Osteri 750mcg injection promotes the formation of new bone tissue and increases bone density. This drug has been demonstrated to accelerate the healing process of bone for those suffering from fractures. It helps to create a callus, the first bridge of bone that develops as healing proceeds, leading to a speedier and more effective recovery.
People who are known to have allergic reactions or hypersensitivity to Osteri 750mcg injection or one of the components are advised to avoid this drug. It is not recommended for people who have a history of skeletal malignancies such as osteosarcoma or who have bone metastases. If a patient has had previous radiation therapy that involved the skeleton, usage of this drug is not recommended due to the possibility of developing osteosarcoma.